⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HROW News
Harrow, Inc. Common Stock
Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026
globenewswire.com
HROW
Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting
globenewswire.com
HROW
Harrow Announces Commercial Launch of BYOOVIZ® in the United States
globenewswire.com
HROW
Form 8-K
sec.gov
HROW
Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare
globenewswire.com
HROW
Form 8-K
sec.gov
HROW
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
globenewswire.com
HROW
HROW Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Harrow for Potential Securities Law Violations
globenewswire.com
HROW
Form 8-K
sec.gov
HROW
Harrow Announces First Quarter 2026 Financial Results
globenewswire.com
HROW